These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 20200976)
1. Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling. Kim HJ; Minashima T; McCarthy EF; Winkles JA; Kirsch T J Bone Miner Res; 2010 Aug; 25(8):1771-83. PubMed ID: 20200976 [TBL] [Abstract][Full Text] [Related]
4. A Phe377del mutation in ANK leads to impaired osteoblastogenesis and osteoclastogenesis in a mouse model for craniometaphyseal dysplasia (CMD). Chen IP; Wang L; Jiang X; Aguila HL; Reichenberger EJ Hum Mol Genet; 2011 Mar; 20(5):948-61. PubMed ID: 21149338 [TBL] [Abstract][Full Text] [Related]
5. Coenzyme q10 regulates osteoclast and osteoblast differentiation. Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186 [TBL] [Abstract][Full Text] [Related]
6. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation. Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673 [TBL] [Abstract][Full Text] [Related]
7. Zinc deficiency decreases osteoblasts and osteoclasts associated with the reduced expression of Runx2 and RANK. Hie M; Iitsuka N; Otsuka T; Nakanishi A; Tsukamoto I Bone; 2011 Dec; 49(6):1152-9. PubMed ID: 21893222 [TBL] [Abstract][Full Text] [Related]
8. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts. Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547 [TBL] [Abstract][Full Text] [Related]
9. Vanin-1 pantetheinase drives increased chondrogenic potential of mesenchymal precursors in ank/ank mice. Johnson KA; Yao W; Lane NE; Naquet P; Terkeltaub RA Am J Pathol; 2008 Feb; 172(2):440-53. PubMed ID: 18187567 [TBL] [Abstract][Full Text] [Related]
10. Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover. Dvorak-Ewell MM; Chen TH; Liang N; Garvey C; Liu B; Tu C; Chang W; Bikle DD; Shoback DM J Bone Miner Res; 2011 Dec; 26(12):2935-47. PubMed ID: 21956637 [TBL] [Abstract][Full Text] [Related]
11. Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone. Hie M; Tsukamoto I Eur J Pharmacol; 2011 Oct; 668(1-2):140-6. PubMed ID: 21806983 [TBL] [Abstract][Full Text] [Related]
12. Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells. Byers BA; GarcĂa AJ Tissue Eng; 2004; 10(11-12):1623-32. PubMed ID: 15684671 [TBL] [Abstract][Full Text] [Related]
13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related]
14. Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling. Sapkota M; Gao M; Li L; Yang M; Shrestha SK; Choi H; Soh Y Eur J Pharmacol; 2020 Sep; 883():173305. PubMed ID: 32673673 [TBL] [Abstract][Full Text] [Related]
15. Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation. Kwun IS; Cho YE; Lomeda RA; Shin HI; Choi JY; Kang YH; Beattie JH Bone; 2010 Mar; 46(3):732-41. PubMed ID: 19913120 [TBL] [Abstract][Full Text] [Related]
16. Osteoblast protects osteoclast devoid of sodium-dependent vitamin C transporters from oxidative cytotoxicity of ascorbic acid. Takarada T; Hinoi E; Kambe Y; Sahara K; Kurokawa S; Takahata Y; Yoneda Y Eur J Pharmacol; 2007 Dec; 575(1-3):1-11. PubMed ID: 17698058 [TBL] [Abstract][Full Text] [Related]
17. Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2(+/-) mice. Zhang X; Ting K; Bessette CM; Culiat CT; Sung SJ; Lee H; Chen F; Shen J; Wang JJ; Kuroda S; Soo C J Bone Miner Res; 2011 Apr; 26(4):777-91. PubMed ID: 20939017 [TBL] [Abstract][Full Text] [Related]
18. The role of the progressive ankylosis protein (ANK) in adipogenic/osteogenic fate decision of precursor cells. Minashima T; Quirno M; Lee YJ; Kirsch T Bone; 2017 May; 98():38-46. PubMed ID: 28286238 [TBL] [Abstract][Full Text] [Related]
19. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption. Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411 [TBL] [Abstract][Full Text] [Related]
20. P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells. Zaka R; Stokes D; Dion AS; Kusnierz A; Han F; Williams CJ Arthritis Res Ther; 2006; 8(6):R164. PubMed ID: 17067391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]